Overview:

Animal placental protein refers to a group of biologically active proteins extracted from the placenta of various mammalian species, including humans, cows, pigs, and sheep. The placenta is a temporary organ that develops during pregnancy and serves as a vital link between the mother and the developing fetus. It provides essential nutrients and oxygen to the fetus while also removing waste products. Placental protein extracts contain a rich array of bioactive substances, such as growth factors, hormones, enzymes, and immunomodulators. These substances are believed to play significant roles in fetal development, tissue repair, and immune system regulation. Placental proteins are thought to promote tissue regeneration and wound healing. They may be used to aid in the recovery of damaged tissues and organs. The immunomodulatory properties of placental proteins may help bolster the immune system and combat certain diseases.

Market Dynamics:

Rising investments by key players is estimated to augment growth of the global animal placental protein market during the forecast period. For instance, Nutrition Technologies has secured millions for recognizing insect protein production in Malaysia, in March 2021. These funds will be beneficial in the substantial enhancement in the Southeast Asian market. Moreover, increasing cost and limited production capability are anticipated to restrain growth of the global animal placental protein market during the forecast period.

Impact of COVID-19:

The pandemic hampered the growth of several economies and industries globally. Strict lockdowns led to shutting down of business across the world. The pandemic also affected the demand and production of animal placental protein. Strict restrictions were imposed in the food industry, owing to disruptions in supply chains. Manufacturing activities of animal placental protein were halted globally, as there was a shortage of raw materials in many regions. This restrained the growth of the global animal placental protein market. Thus, the pandemic had a negative impact on the growth of the global animal placental protein market. However, increasing awareness regarding health among the population is estimated to boost growth of the market.

The Global Animal Placental Protein Market Size was valued at US$ 551.9 million in 2023 and is projected to reach US$ 808.1 million by 2030, at a CAGR of 5.6% from 2023 to 2030. The market is divided into four sections: type, origin, application, and region. The market is divided into two types: hydrolyzed and non-hydrolyzed. Because of its improved solubility and absorption, the hydrolyzed category is expected to rise at a quicker CAGR throughout the forecast period.

Key Takeaways:

The global animal placental protein market is expected to witness high growth, exhibiting CAGR of 5.6 % over the forecast period, due to increasing adoption of inorganic growth strategies. For instance, the Next Generation Manufacturing in Canada was awarded to Aspire Food Group and their partners, in February 2021.

North America is anticipated to witness significant growth in the global animal placental protein market during the forecast period, due to growing geriatric population and increasing rate of menopause population.

Key players operating in the global animal placental protein market are Lee BioSolutions and elabscience, JAPAN BIO PRODUCTS Co., Ltd., Scripps Laboratories, VWR International, Kamiya Biomedical Co, Takara Bio Inc, Insect Technology Group Holdings Limited, Aspire Food Group, Protix, Enviro Flight LLC, Entomo Farms, Swarm Nutrition GmbH, and Next Protein Inc.